Aptorum files amended 8-K updating DiamiR Biosciences financial statementsPUBT·Aug 21 at 09:18 PMAPM0.00%NIKI-4.76%
Aptorum FY26 H1 net loss widens to $1.31 million; operating cash outflow rises to $1.55 millionPUBT·Aug 21 at 09:07 PMAPM0.00%
Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% StakeTradingView·Jul 24 at 08:36 PMNIKI-4.76%APM0.00%
Aptorum Group plans 1-for-10 reverse stock split ahead of DiamiR mergerPUBT·Jul 20 at 12:16 PMAPM0.00%
Aptorum Group Provides Update on DiamiR Biosciences Merger | APM Stock NewsStockTitan·Jul 16 at 07:00 AMAPM0.00%NIKI-4.76%
Aptorum, DiamiR set to close all-stock merger before fiscal 2027, rebrand as Niki BioSolutionsPUBT·Jul 8 at 12:04 PMAPM0.00%NIKI-4.76%
Aptorum amends 6-K to extend DiamiR merger termination date to July 31, 2026PUBT·Jun 22 at 09:01 PMAPM0.00%NIKI-4.76%
Aptorum announces DiamiR-AlzLabs collaboration on blood-based Alzheimer’s biomarkersPUBT·Jun 22 at 12:03 PMAPM0.00%NIKI-4.76%
Aptorum Group shares are trading lower. The company announced shareholder approval of the proposed merger with DiamiR Biosciences.benzinga_article·Jun 10 at 02:18 PMAPM0.00%
Pre-market hot trades in US stocks: Aptorum up 14.85% pre-market; Veru down 14.41% pre-marketPrice Alert·Jun 8 at 09:12 AMAPM0.00%VERU-0.38%
